Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Freeman

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of the American Osteopathic Association|September 19, 2007
Application of incretin mimetics and dipeptidyl peptidase IV inhibitors in managing type 2 diabetes mellitusPatrick J Boyle, Jeffrey S Freeman
The Journal of the American Osteopathic Association|January 24, 2012
Common patient concerns about the use of glucagon-like peptide-1 receptor agonists in diabetes mellitus managementJeffrey S Freeman, James R Gavin, Craig W Spellman
The Journal of the American Osteopathic Association|June 24, 2011
Type 2 diabetes mellitus: practical approaches for primary care physiciansJames R Gavin, Jeffrey S Freeman, Jay H Shubrook, et al.
The Journal of the American Osteopathic Association|June 18, 2010
Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challengesJames R Gavin, Mark W Stolar, Jeffrey S Freeman, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of the American Osteopathic Association|September 19, 2007
Application of incretin mimetics and dipeptidyl peptidase IV inhibitors in managing type 2 diabetes mellitusPatrick J Boyle, Jeffrey S Freeman
The Journal of the American Osteopathic Association|January 24, 2012
Common patient concerns about the use of glucagon-like peptide-1 receptor agonists in diabetes mellitus managementJeffrey S Freeman, James R Gavin, Craig W Spellman
The Journal of the American Osteopathic Association|June 24, 2011
Type 2 diabetes mellitus: practical approaches for primary care physiciansJames R Gavin, Jeffrey S Freeman, Jay H Shubrook, et al.
The Journal of the American Osteopathic Association|June 18, 2010
Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challengesJames R Gavin, Mark W Stolar, Jeffrey S Freeman, et al.
Pageof 3